Efficacy News and Research

RSS
Antacids linked to reduced erlotinib efficacy

Antacids linked to reduced erlotinib efficacy

Alectinib promise for crizotinib-resistant NSCLC

Alectinib promise for crizotinib-resistant NSCLC

C Diff Foundation to present 2014 "Raising C.difficile Awareness" conference in November

C Diff Foundation to present 2014 "Raising C.difficile Awareness" conference in November

New Jersey physician offers FDA-approved non-invasive fat reduction treatment

New Jersey physician offers FDA-approved non-invasive fat reduction treatment

Promising new approach for combating colorectal cancer

Promising new approach for combating colorectal cancer

Distinct patterns of gene expression identified in several groups of pancreatic CTCs

Distinct patterns of gene expression identified in several groups of pancreatic CTCs

TauRx achieves target enrolment in second LMTX Phase III clinical trial for Alzheimer's disease

TauRx achieves target enrolment in second LMTX Phase III clinical trial for Alzheimer's disease

Phase IIa clinical trial data of ATL1102 in MS patients published in journal Neurology

Phase IIa clinical trial data of ATL1102 in MS patients published in journal Neurology

Sequencing the Asian liver fluke genome: an interview with Dr Neil Young

Sequencing the Asian liver fluke genome: an interview with Dr Neil Young

SLU pediatric researcher to study efficacy of new hepatitis C drug treatment in children

SLU pediatric researcher to study efficacy of new hepatitis C drug treatment in children

Viewpoints: Many beneficiaries of health law don't vote; reboot for healthcare.gov

Viewpoints: Many beneficiaries of health law don't vote; reboot for healthcare.gov

Amedica releases Valeo II TL silicon nitride interbody fusion devices

Amedica releases Valeo II TL silicon nitride interbody fusion devices

Reducing insomnia can decrease inflammation, lower risk for chronic disease in older adults

Reducing insomnia can decrease inflammation, lower risk for chronic disease in older adults

Rosuvastatin promotes bone growth in mice with achondroplasia symptoms

Rosuvastatin promotes bone growth in mice with achondroplasia symptoms

Sanofi, MyoKardia partner to develop targeted therapeutics for cardiomyopathies

Sanofi, MyoKardia partner to develop targeted therapeutics for cardiomyopathies

Magnetic resonance: A good method for detecting and quantifying fats in the liver

Magnetic resonance: A good method for detecting and quantifying fats in the liver

Immune begins bertilimumab Phase II clinical trial for treatment of ulcerative colitis

Immune begins bertilimumab Phase II clinical trial for treatment of ulcerative colitis

First data from phase 3 study of investigational once-weekly DPP-4 inhibitor for type 2 diabetes presented by MSD

First data from phase 3 study of investigational once-weekly DPP-4 inhibitor for type 2 diabetes presented by MSD

Ramucirumab effective second-line option for NSCLC

Ramucirumab effective second-line option for NSCLC

Sacral neuromodulation augments efficacy of antimuscarinics in OAB

Sacral neuromodulation augments efficacy of antimuscarinics in OAB

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.